LadRx Corporation (LADX)
Sector: Biotechnology
LadRx Corporation
OTC:LADXHealthcare · Biotechnology
$0.0003
CLOSED · Nov 16Prev close$0.0003Close$0.0003
Mkt Cap$149
EV-
Float492K
O/S497K
VOL3K sh
$ Vol$1
RVOL1.44×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
MCap$149Float492KO/S497K
Dilution
Short interest (FINRA)
- 0.0%
- 214
- 1.04
Oct 30 (18d)
Float 491.71K · FMP free float
Oct 30 (18d)prev 214– 0.0%
Oct 30 (18d)prev 1.00▲ 4.0%
Borrow (IBKR)
The cost to borrow LADX shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.
IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
- No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Latest short interest settlements (today's share basis)
| Date | Shares short |
|---|---|
| Oct 30, 2026 | 214 sh |
| Oct 15, 2026 | 214 sh |
| Sep 30, 2026 | 214 sh |
| Sep 15, 2026 | 214 sh |
| Aug 31, 2026 | 214 sh |
The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.
Off-exchange short volume
FINRA publishes no off-exchange short volume for this symbol.
ATS venues (dark pools)
FINRA's weekly alternative trading system (dark pool) volume for LADX: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.
The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
As of the Oct 30, 2026 FINRA settlement, 214 LADX shares were sold short (0.04% of a 492K-share float, 1.04 days to cover).